10-SEP-2025

Non-steroidal MRAs in CKD and heart failure – clinical practice update

Prof. Hiddo L. Heerspink

Non-steroidal MRAs and SGLT2 inhibitors – a cardiorenal dream team

Show More

10-SEP-2025

Non-steroidal MRAs in CKD and heart failure – clinical practice update

Prof. Linong Ji, Prof. Stefan Anker, Prof. Paola Fioretto, Prof. Hiddo L. Heerspink

Panel discussion

Show More

18-JUN-2025

Education Module 4: New paths to improve outcomes in heart failure with preserved ejection fraction

Prof. Katharina Marx-Schütt

Challenges and unmet needs in treating HFpEF

Show More

18-JUN-2025

Education Module 3: Understanding heart failure treatment: key mechanisms

Prof. Francesco Cosentino

How glucose-lowering drugs transform heart failure treatment

Show More

18-JUN-2025

Education Module 3: Understanding heart failure treatment: key mechanisms

Prof. Paola Fioretto

Two goals in one action: Bridging the potential of non-steroidal MRAs from CKD to heart failure

Show More

05-JUN-2024

Deepening expertise in the management of CKD

Prof. David Cherney

SGLT2 inhibitors in routine clinical care: Looking beyond the results from outcome trials

Show More

05-JUN-2024

Deepening expertise in the management of CKD

Prof. Hiddo L. Heerspink

Optimizing treatment of CKD: SGLT2 inhibitors in combination therapy approaches

Show More

17-APR-2024

Enhancing diagnosis and treatment of CKD

Prof. Per-Henrik Groop

The cardiorenal benefits of SGLT2 inhibitors: Insights from across the CKD spectrum

Show More